Economic evaluation of neonatal intensive care of very-low-birth-weight infants

The New England Journal of Medicine
M BoyleS P Horwood

Abstract

We evaluated the economic aspects of neonatal intensive care of very-low-birth-weight infants, using outcomes and costs of care before and after the introduction of a regional neonatal-intensive-care program. Neonatal intensive care increased both survival rates and costs. For newborns weighing 1000 to 1499 g, the cost (in 1978 Canadian dollars) was $59,500 per additional survivor, $2,900 per life-year gained, and $3,200 per quality-adjusted life-year gained; intensive care resulted in a net economic gain when figures were undiscounted but a net economic loss when future costs, effects, and earnings were discounted at 5 per cent per annum. For infants weighing 500 to 999 g, the corresponding costs were $102,500 per additional survivor, $9,300 per life-year gained, and $22,400 per quality-adjusted life-year gained; intensive care resulted in a net economic loss. By every measure of economic evaluation, the impact of neonatal intensive care was more favorable among infants weighing 1000 to 1499 g than among those weighing 500 to 999 g. A judgment concerning the relative economic value of neonatal intensive care of very-low-birth-weight infants requires a comparison with other health programs.

References

Mar 31, 1977·The New England Journal of Medicine·M C Weinstein, W B Stason
Mar 31, 1977·The New England Journal of Medicine·W B Stason, M C Weinstein
Nov 1, 1979·The Journal of Pediatrics·J T McCarthyL J Butterfield
Dec 1, 1978·American Journal of Epidemiology·J C KleinmanC A Young
Nov 1, 1970·Pediatric Clinics of North America·P R Swyer
Aug 7, 1980·The New England Journal of Medicine·M C Weinstein
Aug 27, 1981·The New England Journal of Medicine·J C SinclairD L Sackett
Jan 1, 1980·American Journal of Public Health·K S LeeL Gruss
Nov 8, 1980·British Medical Journal·E S SteinerC R Maddock

❮ Previous
Next ❯

Citations

Nov 27, 1998·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·P C CoyteB Chan
Apr 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M ApajasaloJ Rautonen
Dec 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M ApajasaloH Sintonen
Jan 1, 1995·Sozial- Und Präventivmedizin·M Mugford
Jan 1, 1985·Sozial- Und Präventivmedizin·E Siegel
Jul 1, 1990·Journal of General Internal Medicine·M C WeinsteinJ M Richter
Mar 1, 1994·Human Nature : an Interdisciplinary Biosocial Perspective·L A Papile
Jul 14, 2001·Indian Journal of Pediatrics·R K PejaverS Aldussari
Apr 20, 2000·Indian Journal of Pediatrics·R ShanmugasundaramJ Shyamala
Jul 8, 2000·Indian Journal of Pediatrics·S Awasthi
Jun 1, 2006·Familial Cancer·Carmel ApicellaJohn L Hopper
Mar 26, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·S SaigalR Hagan
May 1, 1987·American Journal of Obstetrics and Gynecology·E AmonW C Mabie
Jan 1, 1987·Journal of Chronic Diseases·G W Torrance
Jan 1, 1996·Obstetrics and Gynecology·J M GoldfarbM Clapp
Feb 9, 1986·Journal of Health Economics·G W Torrance
Aug 7, 1988·Journal of Health Economics·C DonaldsonK Wright
Feb 7, 1995·Health Policy·M Johannesson
Jan 1, 1987·Social Science & Medicine·M S Patel
Jan 1, 1989·Social Science & Medicine·R A Carr-Hill
May 1, 1992·Social Science & Medicine·J HallJ Richardson
Aug 1, 1995·Social Science & Medicine·M Johannesson
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C WilliamsS Wait
Nov 14, 1997·Obstetrics and Gynecology·S J KilpatrickA Sola
Jun 13, 1987·Lancet
Apr 17, 1999·International Journal of Pediatric Otorhinolaryngology·A Q Summerfield, D H Marshall
Jan 7, 1997·Journal of Health Economics·A M Garber, C E Phelps
Feb 1, 1997·Social Science & Medicine·M RyanJ Tucker
Aug 6, 2002·Resuscitation·Heather GageL Shaikh
May 28, 2003·Journal of Clinical Epidemiology·Jacek A Kopec, Kevin D Willison
Dec 22, 1999·Artificial Intelligence in Medicine·A Manjarrés RiescoJ Mira Mira
Mar 6, 2004·Seminars in Neonatology : SN·T Allen MerrittSusan L Prows
Oct 1, 1993·Journal of Biosocial Science·W P LeongS S Ratnam
Jan 1, 1991·International Journal of Technology Assessment in Health Care·M Goddard, J Hutton
Jan 1, 1990·International Journal of Technology Assessment in Health Care·B R Luce, A Elixhauser
Jan 1, 1996·International Journal of Technology Assessment in Health Care·B KhoshnoodB I Kim
Oct 1, 1996·International Journal of Technology Assessment in Health Care·P Jacobs, J Bachynsky
Jan 1, 1991·International Journal of Technology Assessment in Health Care·J C Sinclair
Jan 1, 1991·International Journal of Technology Assessment in Health Care·U Ewald
Jan 1, 1992·International Journal of Technology Assessment in Health Care·N W Svenningsen
Sep 14, 2001·Emergency Medicine·J BridgesL Haywood

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.